Menu

Videotron Founder Andre Chagnon Dies at Age 94

Andre Chagnon


Andre Chagnon, 1928-2022. Canadian Press
Published Oct. 8, 2022 2:40 p.m.


Andre Chagnon, a Quebec businessman who founded telecommunications giant Videotron and later set up one of the largest family foundations in the country, has died.

In a statement, his family said Chagnon passed away early Saturday at the age of 94, surrounded by loved ones.

The Montreal-born Chagnon, an electrician by trade, was the founder of Videotron in 1964, the Quebec cable television company that would become one of the largest telecommunications companies in Canada.

Videotron was later acquired by Quebecor Media Inc. in 2000, with Chagnon and his widow, Lucie, in turn setting up the Lucie and Andre Chagnon Foundation with a goal of preventing poverty.

Quebec Premier Francois Legault paid tribute to Chagnon as a brilliant and visionary man and someone he had consulted many times during his political career.

Legault said on Twitter that in founding Videotron, Chagnon shaped modern Quebec and highlighted his exceptional efforts to prevent poverty through the family foundation.


In Memoriam

André Chagnon
Visionary & Philanthropist

By George Yu, MD

As his physician and later his friend, André Chagnon will always remain as the modest giant and visionary, both in his leadership as founder of Videotron (the largest telecommunication network in Canada) as well in his thinking and understanding of health and medical intervention without a formal medical education. We will always remember and love him.

Although he never became a board member of the YuFoundation.org, his guidance and generosity surpassed even our founding fathers.

I first met André and his wife Lucie in 2010, where he asked Dr. Mary Newport and me and to review a $15 million dollar donation for an Alzheimer’s disease group in Canada. We ,all three, unanimously agreed the project did not merit such a donation.

On behalf of his beloved wife Lucie, who was plagued with ongoing Alzheimer’s disease, André, Mary Newport and I consulted everywhere, including a prominent group at University of Toronto on brain dysfunction.


André was the first person to introduce me to Axona, Ltd, the creators of the very first metabolic agent targeting Alzheimer’s, which introduced medium- chain fatty acids as a nutritional intervention for Alzheimer’s to the world. We went to University of Wisconsin, which has the largest stem research team in the world and worked with a group studying hormonal intervention for brain function. Our search was wide!

By fortune and chance, we connected with Dr. Richard Veech MD, PhD, at the U.S. National Institute of Health in Washington, DC, who isolated of beta hydroxybutyrate ketone ester as a potential energy substitute for the central nervous system in Alzheimer’s disease. The late Dr. Veech was a protégé of biochemist Hans Krebs, who won the Nobel Prize for discovering Oxidative Phosphorylation (or Krebs Cycle).

Veech then returned to the United States to work with Dr. George Cahill, MD, (one of my teachers at Harvard) who in the 1970s questioned whether small amounts of ketone esters (not the high ketone level in diabetic ketoacidosis) could one day be used as the fuel for life instead of the fast-acting glucose.

André, Mary, and I worked together to provide the initial funding for the excellent clinical research conducted by a fellow Canadian Stephen Cunnane, PhD, at Sherbrooke University.


This research was the first worldwide to use a special PET scan showing the Alzheimer’s disease was a form of Diabetes Type 3, whereby nerve cells could not incorporate glucose as fuel as early as ten (10) years before the onset of memory loss.

Today, we know Dr. Veech’s ketone isolate, beta hydroxybutyrate ketone ester, is a substitute fuel for people Alzheimer’s disease and for endurance heart muscle function.

Dr. George Cahill of Harvard and more recently Dr. Richard Veech of NIH, and André Chagnon have all passed on and so “selflessly” and generously contributed their work so that people like the late Lucie Chagnon can benefit from early detection and nutritional intervention with ketone esters to fuel the brain and the heart without glucose sugar metabolism. May their legacies be remembered by their families and all who benefited from their greatness and contribution.

André Chagnon quietly made progress in science as his “side kick,” without any expectation of gratitude and continued his private life with his extended family.

We are all blessed to have been with him on Earth!

“The achievement of success is not about power, wealth, or prestige but the ability to change the life of the common man.”
Peter Drucker, Sr.

It is changing the life of the common man who may never know who you are!


Lastly, André Chagnon with the late Morgan Wayson, and Ken and the late Joanne Gill made it possible for the Yu Foundation to spend over $500,000 to stage the Tripping over the Truth seminars (TOTT) as a gesture for public awareness and empowerment for the people, who will never know the details that made it possible!

The last time I saw André Chagnon was December 9, 2021, and we parted with many mutual thoughts.




Focus of Foundation

The George W. Yu Foundation for Nutrition & Health supports:

  • Nutrition & metabolism to maintain health
  • Prevention & removal of toxic burden in the body
  • Body & cellular preservation and regeneration stem cell research
  • Natural hormones, sex hormones, menopause, andropause, breast & prostate cancer

The Measurement of Achievement

“It is not enough to be remembered for one's wealth, knowledge, and achievements. One does not make a difference unless it is the difference in people's lives."

- Joseph Schumpeter, Adolph Drucker The World According to Peter Drucker 1998

"More so, the mark of true achievement and truth is to change the life of the common man who will never know who you are" - George Yu, M.D. 2006

  • We are not satisfied with just public awareness but demand public empowerment.
  • We are ordinary people doing extraordinary things.

Immediate Goal

Metabolic approach to Cancer Disease

The metabolic approach to cancer embraces nutritional and molecular aspects to "Starve the cancer cells to death" without harm to the host being. Nutritional intervention means eating foods with calorie restriction, optimal nutrition ketosis (CRONK) high nutrition but with low calories (CR-caloric restriction). Molecular intervention means studying and using compounds, which will block the cancer cell metabolism and energy production.


METABOLIC APPROACH TO CANCER

Paradigm Shift, Needing a "Tipping Point"


Nuclear Transfer Studies of Cancer Cells

Paradigm Shift

This concept differs from a "nuclear genetic" or Somatic Mutational Theory approach which uses agents that destroy indiscriminately both cancer growth and the host being. We emphasize a unique feature in most cancers, which require abundant sugars and some specific amino acids molecules for its energy and growth. Depriving the source of energy leads to cancer cell death without hurting the rest of your body.

Massive public awareness of the concept and evidence supporting a metabolic approach to cancer both in research and treatment must become a reality. We want the individual, institutions and "crowd thinking" via social media to create the momentum to support this concept and future work.

We must unite the use of nutrition practices using CR and metabolic blocking compounds as one integrated practice to deplete energy production of cancer cells.

There are a growing number of scientists and medical doctors who are approaching cancer research and treatments from a metabolic model of cancer starvation and depriving cancer cells of "ATP energy production." I believe the "Tipping Point" (Malcolm Gladwell) is close at hand in a change in the paradigm from Somatic Mutation to a Metabolic theory of carcinomatosis.


Are you someone who has a loved one who has cancer who is failing traditional treatments?

Are you someone who asked your doctor what you can do yourself to help cure the cancer and the answer is NONE!

We are reaching out to you to share what we know and ask for your help to spread the news to others.

Progress in Cancer Treatments
"It takes more than one tool but many specialized tools to make a good sitting chair."

A Major Initiative

We have the right team and now we just need Two generous partners.

Total Project Cost: $131,340

After going to the beach and taking a short swim, have you wondered why you "feel so great!"


TOTT Seminar & Courses


Donations
No more than 10% of our donations go to general expense. 90% must go to research.


We Need Your Pre-Tax Donations!